Gosse M E, Fleischmann R, Marshall M, Wang N, Garges S, Gottesman M M
Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
Biochem J. 1994 Jan 1;297 ( Pt 1)(Pt 1):79-85. doi: 10.1042/bj2970079.
The type-I regulatory subunit (RI) of the cyclic AMP-dependent protein kinase (PKA) from Chinese hamster ovary (CHO) cells has been cloned and expressed in a strain of BL21(DE3) Escherichia coli lacking adenylate cyclase [BL21(DE3)/delta cya]. RI expressed in this bacterial system free of cyclic AMP is soluble and can reconstitute functional PKA. Recombinant CHO C alpha is predominantly insoluble with some active soluble protein. C beta is entirely insoluble and inactive. Soluble recombinant RI and soluble recombinant C alpha can associate in vitro and be activated by cyclic AMP. Six site-directed mutations of RI were generated to study the interaction of cyclic AMP with RI and RI-C alpha subunit interactions. Four cyclic AMP-binding-site point mutants were generated [W261R (tryptophan to arginine at position 261), a novel mutation in site A; V376G, a novel mutation in site B; G200E (site A), and Y370F (site B), previously described in bovine RI were introduced into the CHO RI for comparison purposes]. Mutants W261R, Y370F, and G200E demonstrated decreased 8-N3-[3H]cyclic AMP binding as well as 5-fold reduced affinity for [3H]cyclic AMP, with threefold increased EC50 values for cyclic AMP activation of kinase activity from reconstituted mutant holoenzymes. The mutation at V376G did not alter cyclic AMP binding or activation by cyclic AMP of mutant holoenzyme. A truncation mutant, G200Stop, which lacks both cyclic AMP-binding sites, did not bind cyclic AMP but can inhibit C alpha subunit activity. A novel mutation outside the cyclic AMP-binding regions of RI (V89A) weakened the interaction with C alpha indicated by a 7-fold lower EC50 for mutant holoenzyme activation by cyclic AMP.
已克隆出中国仓鼠卵巢(CHO)细胞中环磷酸腺苷依赖性蛋白激酶(PKA)的I型调节亚基(RI),并在缺乏腺苷酸环化酶的BL21(DE3)大肠杆菌菌株[BL21(DE3)/delta cya]中进行表达。在这个不含环磷酸腺苷的细菌系统中表达的RI是可溶的,并且能够重组功能性PKA。重组的CHO Cα主要是不溶的,只有一些具有活性的可溶性蛋白。Cβ完全不溶且无活性。可溶性重组RI和可溶性重组Cα在体外可以结合,并被环磷酸腺苷激活。为了研究环磷酸腺苷与RI的相互作用以及RI-Cα亚基的相互作用,对RI进行了六个位点定向突变。产生了四个环磷酸腺苷结合位点点突变体[W261R(第261位色氨酸突变为精氨酸),位点A中的一个新突变;V376G,位点B中的一个新突变;G200E(位点A),以及Y370F(位点B),先前在牛RI中描述过,为了比较目的将其引入CHO RI]。突变体W261R、Y370F和G200E表现出8-N3-[3H]环磷酸腺苷结合减少,以及对[3H]环磷酸腺苷的亲和力降低5倍,重组突变全酶的激酶活性被环磷酸腺苷激活的EC50值增加了三倍。V3